Literature DB >> 19218134

[Role of CD4+CD25+Foxp3+ regulatory T cells in type 2 diabetic nephropathy].

Jing Xu1, Hong-li Su, Jun-hong Wang, Chun-hong Zhang.   

Abstract

OBJECTIVE: To investigate the role of CD4+CD25+Foxp3+ regulatory T cells (Treg) in type 2 diabetic nephropathy and provide new clues for prevention and treatment of type 2 diabetic nephropathy.
METHODS: Flow cytometry was used to analyze the expression rate of CD4+CD25+Foxp3+ Treg cells in 60 patients with type 2 diabetes and 15 normal subjects.
RESULTS: No significant difference was found in the expression rate of CD4+CD25+Foxp3+ Treg cells between the control group and the type 2 diabetic patients. In the type 2 diabetic patients with microalbuminuria and macroalbuminuria, the expression of CD4+CD25+Foxp3+ Treg cells was significantly lowered in comparison with that in the control group (P<0.05), and patients with macroalbuminuria showed significantly lower expression of CD4+CD25+Foxp3+ Treg cells than the microalbuminuric patinets (P<0.05). Significant inverse correlations were noted between the disease course and the expression of CD4+CD25+Foxp3+ Treg cells and between the urinary albumin excretion rate (UAER) and the expression of CD4+CD25+Foxp3+ Treg cells.
CONCLUSION: CD4+CD25+Foxp3+ Treg cells may play a role in the occurrence and development of type 2 diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218134

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  10 in total

1.  Increased circulating cytokine levels in African American women with obesity and elevated HbA1c.

Authors:  Ariel Williams; Natasha Greene; K Kimbro
Journal:  Cytokine       Date:  2020-01-28       Impact factor: 3.861

Review 2.  Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Authors:  Raimund Pichler; Maryam Afkarian; Brad P Dieter; Katherine R Tuttle
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-24

Review 3.  Regulatory T cells in acute and chronic kidney diseases.

Authors:  Rahul Sharma; Gilbert R Kinsey
Journal:  Am J Physiol Renal Physiol       Date:  2017-09-06

4.  Resveratrol Ameliorates Diabetes-induced Renal Damage through Regulating the Expression of TGF-β1, Collagen IV and Th17/Treg-related Cytokines in Rats.

Authors:  Zhou Wenbin; Gao Guojun
Journal:  West Indian Med J       Date:  2014-04-08       Impact factor: 0.171

Review 5.  Role of T cells in type 2 diabetic nephropathy.

Authors:  Chia-Chao Wu; Huey-Kang Sytwu; Kuo-Cheng Lu; Yuh-Feng Lin
Journal:  Exp Diabetes Res       Date:  2011-10-19

Review 6.  Diabetic nephropathy - complications and treatment.

Authors:  Andy Kh Lim
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-10-15

Review 7.  Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Yong-Chao Qiao; Jian Shen; Lan He; Xue-Zhi Hong; Fang Tian; Yan-Hong Pan; Ling Liang; Xiao-Xi Zhang; Hai-Lu Zhao
Journal:  J Diabetes Res       Date:  2016-09-29       Impact factor: 4.011

8.  Novel Immunomodulatory Cytokine Regulates Inflammation, Diabetes, and Obesity to Protect From Diabetic Nephropathy.

Authors:  Vikram Sabapathy; Marta E Stremska; Saleh Mohammad; Rebecca L Corey; Poonam R Sharma; Rahul Sharma
Journal:  Front Pharmacol       Date:  2019-05-22       Impact factor: 5.810

Review 9.  Tregs and kidney: From diabetic nephropathy to renal transplantation.

Authors:  Periklis Dousdampanis; Kostantina Trigka; Athanasia Mouzaki
Journal:  World J Transplant       Date:  2016-09-24

Review 10.  Regulatory T cells in renal disease.

Authors:  Maliha A Alikhan; Megan Huynh; A Richard Kitching; Joshua D Ooi
Journal:  Clin Transl Immunology       Date:  2018-01-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.